Published in Proc Natl Acad Sci U S A on September 01, 1993
Albumin binding of unconjugated [3H]bilirubin and its uptake by rat liver basolateral plasma membrane vesicles. Biochem J (1996) 1.46
Expression and function of renal and hepatic organic anion transporters in extrahepatic cholestasis. World J Gastroenterol (2012) 0.79
Structural analysis of a peptide fragment of transmembrane transporter protein bilitranslocase. PLoS One (2012) 0.78
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Measurement of protein using bicinchoninic acid. Anal Biochem (1985) 74.03
An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study. J Cell Biol (1967) 12.04
Fibronectins: multifunctional modular glycoproteins. J Cell Biol (1982) 8.05
STUDIES ON PLASMA MEMBRANES. I. CHEMICAL COMPOSITION AND ENZYME CONTENT OF PLASMA MEMBRANES ISOLATED FROM RAT LIVER. Biochim Biophys Acta (1964) 5.44
On the mechanism of Na+- and K+-stimulated hydrolysis of adenosine triphosphate. 1. Purification and properties of a Na+-and K+-activated ATPase from ox brain. Eur J Biochem (1967) 1.92
Purification of rat liver 5'-nucleotidase as a complex with sphingomyelin. Methods Enzymol (1974) 1.45
Identification, purification, and partial characterization of an organic anion binding protein from rat liver cell plasma membrane. J Clin Invest (1980) 1.28
Influence of Cl- on organic anion transport in short-term cultured rat hepatocytes and isolated perfused rat liver. J Clin Invest (1987) 1.27
Role of plasma membrane ligand-binding proteins in the hepatocellular uptake of albumin-bound organic anions. Hepatology (1987) 1.21
Sodium-dependent alanine transport in plasma-membrane vesicles from rat liver. Biochem J (1978) 1.18
Preparation of [35S]sulfobromophthalein of high specific activity. Anal Biochem (1989) 1.11
Physicochemical and immunohistological studies of a sulfobromophthalein- and bilirubin-binding protein from rat liver plasma membranes. J Clin Invest (1983) 1.10
Biochemical and molecular aspects of the hepatic uptake of organic anions. Biochim Biophys Acta (1990) 1.03
Expression of the hepatocellular chloride-dependent sulfobromophthalein uptake system in Xenopus laevis oocytes. J Clin Invest (1991) 1.02
Isolation of an organic anion binding protein from rat liver plasma membrane fractions by affinity chromatography. Biochem Biophys Res Commun (1979) 0.94
Hepatocellular uptake of sulfobromophthalein and bilirubin is selectively inhibited by an antibody to the liver plasma membrane sulfobromophthalein/bilirubin binding protein. J Clin Invest (1986) 0.93
Reconstitution in vitro of sulfobromophthalein transport by bilitranslocase. Biochim Biophys Acta (1982) 0.90
Bilitranslocase localization and function in basolateral plasma membrane of renal proximal tubule in rat. Am J Physiol (1990) 0.86
The kinetics of sulfobromophthalein uptake by rat liver sinusoidal vesicles. Biochim Biophys Acta (1987) 0.86
Bilitranslocase is the protein responsible for the electrogenic movement of sulfobromophthalein in plasma membrane vesicles from rat liver: immunochemical evidence using mono- and poly-clonal antibodies. Biochim Biophys Acta (1989) 0.80
Reconstitution of sulfobromophthalein transport in erythrocyte membranes induced by bilitranslocase. Biochim Biophys Acta (1990) 0.78
Carrier-mediated transport of tetrabromosulfonephthalein by rat liver plasma membrane vesicles. Am J Physiol (1992) 0.78
Isolation of bilitranslocase, the anion transporter from liver plasma membrane for bilirubin and other organic anions. Methods Enzymol (1989) 0.77
Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion? Nat Med (1996) 5.09
Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med (2000) 4.92
Long-term survival in patients with hereditary hemochromatosis. Gastroenterology (1996) 4.00
Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med (1985) 3.73
Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut (1997) 3.25
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med (1995) 3.20
p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med (1998) 2.91
Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut (2006) 2.53
Macrolide-induced Churg-Strauss syndrome in a patient with atopy. Lancet (1997) 2.42
Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest (1997) 2.32
Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases. J Clin Microbiol (1998) 2.26
TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. Cell Death Differ (2005) 2.25
Perforation of the esophagus after dilation treatment for dysphagia in a patient with eosinophilic esophagitis. Endoscopy (2006) 2.24
Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol (1996) 2.17
Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis. Aliment Pharmacol Ther (2014) 2.15
Risk of infection with Helicobacter pylori and hepatitis A virus in different groups of hospital workers. Am J Gastroenterol (1997) 2.09
Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology (1994) 2.02
Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol (1997) 1.92
Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C. Gut (2007) 1.91
Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. J Clin Invest (1998) 1.86
Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol (1993) 1.81
Is stenting necessary after balloon dilation of post-transplantation biliary strictures? Results of a prospective comparative study. Endoscopy (2008) 1.76
Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Cell Death Differ (2004) 1.62
Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc Natl Acad Sci U S A (1985) 1.55
Phenprocoumon for prevention of shunt occlusion after transjugular intrahepatic portosystemic stent shunt: a randomized trial. Hepatology (1996) 1.53
Late diagnosis of Wilson's disease in a case without onset of symptoms. Acta Neurol Scand (1995) 1.52
Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson's disease. J Hepatol (1994) 1.52
Hepatocellular uptake of oleate is energy dependent, sodium linked, and inhibited by an antibody to a hepatocyte plasma membrane fatty acid binding protein. Proc Natl Acad Sci U S A (1986) 1.50
Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study. Gut (1999) 1.49
Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates. Eur J Gastroenterol Hepatol (2001) 1.48
Albumin binding of unconjugated [3H]bilirubin and its uptake by rat liver basolateral plasma membrane vesicles. Biochem J (1996) 1.46
The spectrum of liver disease in the general population: lesson from the Dionysos study. J Hepatol (2001) 1.43
Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat Med (1998) 1.42
Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS. Infect Immun (2001) 1.40
Severity of liver disease with different hepatitis C viral clones. Lancet (1991) 1.40
Establishment of persistent hepatitis C virus infection and replication in vitro. J Gen Virol (1997) 1.35
High prevalence of celiac disease in Italian general population. Dig Dis Sci (2001) 1.34
The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol (2005) 1.34
Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Dig Dis Sci (1997) 1.34
Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab (1997) 1.32
Predictors of non-alcoholic fatty liver disease in obese children. Eur J Clin Nutr (2006) 1.31
Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoElectrospray-tandem mass spectrometry. Scand J Gastroenterol (2004) 1.29
Familial clustering of Helicobacter pylori infection: population based study. BMJ (1999) 1.29
Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clin Exp Immunol (1998) 1.27
Hepatocellular influx of [14C]oleate reflects membrane transport rather than intracellular metabolism or binding. Proc Natl Acad Sci U S A (1986) 1.26
Mouse fatty acid transport protein 4 (FATP4): characterization of the gene and functional assessment as a very long chain acyl-CoA synthetase. Gene (2001) 1.24
Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? Diabetologia (1984) 1.23
Role of plasma membrane ligand-binding proteins in the hepatocellular uptake of albumin-bound organic anions. Hepatology (1987) 1.21
Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology (1997) 1.20
Differences in the regulation of iron regulatory protein-1 (IRP-1) by extra- and intracellular oxidative stress. J Biol Chem (1997) 1.19
Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J Biol Chem (1997) 1.17
Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: in vivo and in vitro studies. Immunology (1996) 1.17
Structure and binding of unconjugated bilirubin: relevance for physiological and pathophysiological function. J Lipid Res (1994) 1.16
Identification, isolation, and partial characterization of a fatty acid binding protein from rat jejunal microvillous membranes. J Clin Invest (1985) 1.16
Direct determination of Helicobacter pylori vacA genotypes and cagA gene in gastric biopsies and relationship to gastrointestinal diseases. Am J Gastroenterol (1999) 1.16
Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy. J Hepatol (1992) 1.15
Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases. Brain Res Bull (2001) 1.14
Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. J Med Virol (1994) 1.10
Physicochemical and immunohistological studies of a sulfobromophthalein- and bilirubin-binding protein from rat liver plasma membranes. J Clin Invest (1983) 1.10
Interleukin-6 expression and regulation in rat enteric glial cells. Am J Physiol Gastrointest Liver Physiol (2001) 1.10
Direct evidence for catalase as the predominant H2O2 -removing enzyme in human erythrocytes. Blood (1997) 1.08
Protein-mediated facilitated uptake processes for fatty acids, bilirubin, and other amphipathic compounds. Proc Soc Exp Biol Med (1996) 1.07
New concepts in bilirubin encephalopathy. Eur J Clin Invest (2003) 1.07
Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders. Gut (2003) 1.05
[Integrated skills laboratory concept for undergraduate training in internal medicine]. Dtsch Med Wochenschr (2005) 1.05
Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes. J Hepatol (1998) 1.04
Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors. Cancer Gene Ther (2001) 1.04
The preS1 domain of hepatitis B virus and IgA cross-react in their binding to the hepatocyte surface. J Gen Virol (1992) 1.03
Biochemical and immunohistochemical evidence that in cartilage an alkaline phosphatase is a Ca2+-binding glycoprotein. J Cell Biol (1986) 1.03
Biochemical and molecular aspects of the hepatic uptake of organic anions. Biochim Biophys Acta (1990) 1.03
Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study. J Hepatol (1997) 1.02
Studies of albumin binding to rat liver plasma membranes. Implications for the albumin receptor hypothesis. Biochim Biophys Acta (1983) 1.01
Procalcitonin is a valid marker of infection in decompensated cirrhosis. Z Gastroenterol (2003) 1.00
IRP1 activation by extracellular oxidative stress in the perfused rat liver. J Biol Chem (2001) 1.00
Determination of catalase activity at physiological hydrogen peroxide concentrations. Anal Biochem (1997) 0.99
Temporary placement of fully covered self-expandable metal stents in biliary complications after liver transplantation. Endoscopy (2012) 0.99
Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents. Biochem Biophys Res Commun (1999) 0.98
Studies of oleate binding to rat liver plasma membranes. Biochem Biophys Res Commun (1983) 0.98
HJV gene mutations in European patients with juvenile hemochromatosis. Clin Genet (2005) 0.98
Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes. Eur J Clin Invest (2000) 0.97
The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade. Biochimie (2007) 0.96
Iron uptake by human upper small intestine microvillous membrane vesicles. Indication for a facilitated transport mechanism mediated by a membrane iron-binding protein. J Clin Invest (1990) 0.96
The products of YCF1 and YLL015w (BPT1) cooperate for the ATP-dependent vacuolar transport of unconjugated bilirubin in Saccharomyces cerevisiae. Yeast (2000) 0.95
DNA oxidative damage in leukocytes correlates with the severity of HCV-related liver disease: validation in an open population study. J Hepatol (2001) 0.95
The hepatic microvascular responses to sepsis. Semin Thromb Hemost (2000) 0.94
Cohort effect of HCV infection in liver cirrhosis assessed by a 25 year study. J Clin Virol (2000) 0.94
HFE downregulates iron uptake from transferrin and induces iron-regulatory protein activity in stably transfected cells. Blood (1999) 0.94
Localization of the Wilson's disease protein in human liver. Gastroenterology (1999) 0.94
Survival and causes of death in hemochromatosis. Observations in 163 patients. Ann N Y Acad Sci (1988) 0.93
A novel two-nucleotide deletion in the ornithine transcarbamylase gene causing fatal hyperammonia in early pregnancy. Hepatology (1996) 0.93
Interferon therapy in chronic hepatitis C virus: evidence of different outcome with respect to different viral strains. J Med Virol (1995) 0.93
Mild respiratory distress after wireless capsule endoscopy. Gut (2004) 0.93
Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis. Aliment Pharmacol Ther (2014) 0.93
Hepatocellular uptake of sulfobromophthalein and bilirubin is selectively inhibited by an antibody to the liver plasma membrane sulfobromophthalein/bilirubin binding protein. J Clin Invest (1986) 0.93
Affinity of human serum albumin for bilirubin varies with albumin concentration and buffer composition: results of a novel ultrafiltration method. J Biol Chem (2001) 0.93
Isolation of a sulfobromophthalein-binding protein from hepatocyte plasma membrane. Biochim Biophys Acta (1978) 0.93
Different morphologic aspects and clinical features in massive hepatic amyloidosis. Digestion (1984) 0.93
HBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markers. J Clin Pathol (2006) 0.92